Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS): A Prospective, Multi-Center, Randomized-Controlled Clinical Trial

NCT04937803 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT04937803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS): A Prospective, Multi-Center, Randomized-Controlled Clinical Trial
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Completed
Start date
April 19, 2021
Completion date
November 17, 2023
Enrollment
216 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acs, acute coronary syndromes, clinical trial, coronary artery disease, dcb, de novo stenosis, drug-coated balloon